AMT MOLECULAR DIAGNOSTICS TECHNOLOGIST (MDT) CERTIFICATION EXAM QUESTIONS AND CORRECT
ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A | INSTANT DOWNLOAD PDF.
Core Domains
Molecular Biology Fundamentals and Techniques
Nucleic Acid Extraction and Amplification
Hybridization, Sequencing, and Microarray Technologies
Quality Management and Quality Control in Molecular Diagnostics
Regulatory Compliance (CLIA, CAP, FDA) and Biosafety
Interpretation of Molecular Test Results and Variant Analysis
Laboratory Operations, Troubleshooting, and Informatics
Ethics, Professional Standards, and Patient Confidentiality
Introduction
This examination assesses the knowledge, critical thinking, and decision-making skills required for competent
practice as an AMT Molecular Diagnostics Technologist. It covers foundational molecular biology, applied
laboratory techniques, regulatory compliance, quality assurance, ethical conduct, and real-world scenario-based
problem-solving. Questions are structured as multiple-choice with single best answers, reflecting the integration of
theory with clinical and laboratory decision-making. Candidates must demonstrate the ability to interpret results,
troubleshoot assays, adhere to legal standards, and apply professional judgment in diverse molecular diagnostics
settings.
,SECTION ONE: QUESTIONS 1–100
Question 1
A technologist notices that all positive controls in a real-time PCR run fail to amplify, while negative controls are
negative. The patient samples show no amplification. What is the most likely cause?
A. Reagents were prepared incorrectly, omitting the reverse primer
B. The thermal cycler heating block is malfunctioning only in specific wells
C. DNA polymerase activity was inhibited by a carryover contaminant
D. The fluorescent probe concentration was tenfold too high
🟢A
🔴 RATIONALE: Omitting the reverse primer prevents exponential amplification in all reactions, including
positive controls, while negative controls remain negative. A malfunctioning block would affect only some wells.
Inhibition would not equally abolish all positive controls unless universal. Excess probe increases background
but not complete failure.
Question 2
Which of the following is an example of a post-analytical error in molecular diagnostics?
A. Incorrect specimen labeling at the time of collection
B. RNA degradation due to delayed freezing of the sample
C. Transcription of a heterozygous variant as homozygous in the final report
D. Failure of the thermocycler lid to heat during amplification
🟢C
,🔴 RATIONALE: Post-analytical errors occur after testing, during data interpretation or reporting. Transcribing a
variant incorrectly is a post-analytical clerical error. Pre-analytical errors include labeling (A) and degradation (B).
Analytical errors include equipment failure (D).
Question 3
A laboratory wishes to detect a single nucleotide substitution in a cancer biopsy with very low mutant allele
frequency (1%). Which method is most appropriate?
A. Sanger sequencing
B. Standard end-point PCR with gel electrophoresis
C. Digital PCR (dPCR)
D. Southern blot
🟢C
🔴 RATIONALE: Digital PCR partitions the sample into thousands of reactions, enabling sensitive detection of
rare mutations down to 0.1%. Sanger sequencing typically requires >20% mutant allele frequency. End-point
PCR and Southern blot lack sensitivity for low-abundance variants.
Question 4
Under CLIA regulations for high-complexity molecular testing, who is authorized to perform the initial review of
quality control data before patient results are released?
A. The laboratory director only
B. Any testing personnel who passed competency assessment
C. A qualified technologist designated by the laboratory director
D. The referring physician
, 🟢C
🔴 RATIONALE: CLIA allows designated qualified testing personnel to review QC data under director oversight.
The director does not need to personally review every QC; delegation is permitted. The referring physician is not
involved in internal QC review.
Question 5
A patient sample yields an invalid result in an RT-PCR assay for an RNA virus due to the presence of an internal
control that does not amplify. The patient’s target is negative. What is the most appropriate next step?
A. Report the patient result as negative for the virus
B. Repeat the test from the original specimen after checking extraction efficiency
C. Dilute the sample 1:10 and re-run to remove inhibitors
D. Change the threshold setting in the analysis software
🟢B
🔴 RATIONALE: Internal control failure indicates a problem with extraction or amplification; results are invalid.
The test must be repeated from the original specimen. Reporting without valid control is unacceptable. Dilution
may help inhibitors but should not be first without checking extraction.
Question 6
What is the function of the tet gene commonly found in plasmid vectors used for molecular cloning?
A. Antibiotic resistance for selection of transformed bacteria
B. Reporter gene for measuring promoter activity
C. Origin of replication for plasmid copy number control
D. Restriction site for linearizing the vector
ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A | INSTANT DOWNLOAD PDF.
Core Domains
Molecular Biology Fundamentals and Techniques
Nucleic Acid Extraction and Amplification
Hybridization, Sequencing, and Microarray Technologies
Quality Management and Quality Control in Molecular Diagnostics
Regulatory Compliance (CLIA, CAP, FDA) and Biosafety
Interpretation of Molecular Test Results and Variant Analysis
Laboratory Operations, Troubleshooting, and Informatics
Ethics, Professional Standards, and Patient Confidentiality
Introduction
This examination assesses the knowledge, critical thinking, and decision-making skills required for competent
practice as an AMT Molecular Diagnostics Technologist. It covers foundational molecular biology, applied
laboratory techniques, regulatory compliance, quality assurance, ethical conduct, and real-world scenario-based
problem-solving. Questions are structured as multiple-choice with single best answers, reflecting the integration of
theory with clinical and laboratory decision-making. Candidates must demonstrate the ability to interpret results,
troubleshoot assays, adhere to legal standards, and apply professional judgment in diverse molecular diagnostics
settings.
,SECTION ONE: QUESTIONS 1–100
Question 1
A technologist notices that all positive controls in a real-time PCR run fail to amplify, while negative controls are
negative. The patient samples show no amplification. What is the most likely cause?
A. Reagents were prepared incorrectly, omitting the reverse primer
B. The thermal cycler heating block is malfunctioning only in specific wells
C. DNA polymerase activity was inhibited by a carryover contaminant
D. The fluorescent probe concentration was tenfold too high
🟢A
🔴 RATIONALE: Omitting the reverse primer prevents exponential amplification in all reactions, including
positive controls, while negative controls remain negative. A malfunctioning block would affect only some wells.
Inhibition would not equally abolish all positive controls unless universal. Excess probe increases background
but not complete failure.
Question 2
Which of the following is an example of a post-analytical error in molecular diagnostics?
A. Incorrect specimen labeling at the time of collection
B. RNA degradation due to delayed freezing of the sample
C. Transcription of a heterozygous variant as homozygous in the final report
D. Failure of the thermocycler lid to heat during amplification
🟢C
,🔴 RATIONALE: Post-analytical errors occur after testing, during data interpretation or reporting. Transcribing a
variant incorrectly is a post-analytical clerical error. Pre-analytical errors include labeling (A) and degradation (B).
Analytical errors include equipment failure (D).
Question 3
A laboratory wishes to detect a single nucleotide substitution in a cancer biopsy with very low mutant allele
frequency (1%). Which method is most appropriate?
A. Sanger sequencing
B. Standard end-point PCR with gel electrophoresis
C. Digital PCR (dPCR)
D. Southern blot
🟢C
🔴 RATIONALE: Digital PCR partitions the sample into thousands of reactions, enabling sensitive detection of
rare mutations down to 0.1%. Sanger sequencing typically requires >20% mutant allele frequency. End-point
PCR and Southern blot lack sensitivity for low-abundance variants.
Question 4
Under CLIA regulations for high-complexity molecular testing, who is authorized to perform the initial review of
quality control data before patient results are released?
A. The laboratory director only
B. Any testing personnel who passed competency assessment
C. A qualified technologist designated by the laboratory director
D. The referring physician
, 🟢C
🔴 RATIONALE: CLIA allows designated qualified testing personnel to review QC data under director oversight.
The director does not need to personally review every QC; delegation is permitted. The referring physician is not
involved in internal QC review.
Question 5
A patient sample yields an invalid result in an RT-PCR assay for an RNA virus due to the presence of an internal
control that does not amplify. The patient’s target is negative. What is the most appropriate next step?
A. Report the patient result as negative for the virus
B. Repeat the test from the original specimen after checking extraction efficiency
C. Dilute the sample 1:10 and re-run to remove inhibitors
D. Change the threshold setting in the analysis software
🟢B
🔴 RATIONALE: Internal control failure indicates a problem with extraction or amplification; results are invalid.
The test must be repeated from the original specimen. Reporting without valid control is unacceptable. Dilution
may help inhibitors but should not be first without checking extraction.
Question 6
What is the function of the tet gene commonly found in plasmid vectors used for molecular cloning?
A. Antibiotic resistance for selection of transformed bacteria
B. Reporter gene for measuring promoter activity
C. Origin of replication for plasmid copy number control
D. Restriction site for linearizing the vector
